Growth Metrics

908 Devices (MASS) EBITDA Margin (2020 - 2026)

908 Devices (MASS) reported EBITDA Margin of 96.29% for Q1 2026, down 266.0% year-over-year from 58.0% in Q1 2025, and down 641.22% on a QoQ basis from 17.79% in Q4 2025.

908 Devices (MASS) has 7 years of EBITDA Margin data on file, last reported at 96.29% in Q1 2026.

  • Quarterly EBITDA Margin fell 266.0% year-over-year to 96.29% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 71.41% (up 4530.0% YoY) and the FY2025 annual result came in at 70.15%, up 5006.0% from the prior year.
  • EBITDA Margin slipped to 96.29% in Q1 2026 per MASS's latest filing, from 17.79% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 17.79% in Q4 2025 and bottomed at 168.7% in Q3 2024.
  • The 5-year median for EBITDA Margin is 93.62% (2025), against an average of 91.2%.
  • The widest annual swing landed in 2024, when EBITDA Margin plunged 10513 bps; it then jumped 13457 bps in 2025.
  • Tracing MASS's EBITDA Margin over 5 years: stood at 88.79% in 2022, then rose by 24 bps to 67.68% in 2023, then slumped by 73 bps to 116.77% in 2024, then surged by 115 bps to 17.79% in 2025, then sank by 641 bps to 96.29% in 2026.
  • Per Business Quant, the three latest MASS EBITDA Margin figures stand at 96.29% (Q1 2026), 17.79% (Q4 2025), and 116.56% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 908 Devices 314.43 Mn 202.69 Mn 6.88 Mn -96.29%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -96.29%
Dec 31, 2025 17.79%
Sep 30, 2025 -116.56%
Jun 30, 2025 -116.31%
Mar 31, 2025 -93.62%
Dec 31, 2024 -116.77%
Sep 30, 2024 -168.70%
Jun 30, 2024 -74.50%
Mar 31, 2024 -102.55%
Dec 31, 2023 -67.68%
Sep 30, 2023 -63.57%
Jun 30, 2023 -90.45%
Mar 31, 2023 -137.21%
Dec 31, 2022 -88.79%
Sep 30, 2022 -45.29%
Jun 30, 2022 -75.36%
Mar 31, 2022 -114.63%
Dec 31, 2021 -22.27%
Sep 30, 2021 -42.06%
Jun 30, 2021 -90.07%
Mar 31, 2021 -104.82%
Dec 31, 2020 -67.97%
Sep 30, 2020 -21.38%
Jun 30, 2020 19.12%
Mar 31, 2020 -69.08%